Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us


Session 127   Poster Abstracts
Antiretroviral Therapy in Children
Monday, 1:30 - 3:30 pm
Poster Hall
924Improvements in the Clinical Status of HIV-infected Children; a Longitudinal Assessment of the Effects of Advances in Care
K Dominguez*1, E Handelsman2, M Paul3, T Sukalac1, M G Fowler1, I Ortiz4, H Hsu5, S Melville3, T Rakusan6, V Peters7, T Frederick8, PSD Consortium1, and PSD Consortium
1CDC, Atlanta, GA, USA; 2State Univ. of New York Downstate, Brooklyn, USA; 3Texas Dept. of Hlth., Austin, USA; 4Hlth. Dept., San Juan, PR, USA; 5Massachusetts State Labs., Jamaica Plain, MA, USA; 6Children's Natl. Med. Ctr., Washington, DC, USA; 7New York City Dept. of Hlth., NY, USA; and 8Los Angeles County Dept. of Hlth. Svcs., CA, USA
925Early Therapy in Vertically HIV-1 infected Children: Effect on the Natural Course of HIV-1 Infection
M Zanchetta1, N Burighel1, D Bellanova1, C Giaquinto2, A Mazza3, and A De Rossi*1
1AIDS Reference Ctr., Univ. of Padova, Italy; 2Univ. of Padova, Italy; and 3Hosp. Trento Pediatric Unit, Italy
926
Evolution of Genotypic Resistance and Pharmacokinetic Measures of Adherence in Children Failing Ritonavir/Indinavir Combination Regimens
E G Chadwick*1, J H Rodman2, P M Samson3, L Petch4, S Fiscus4, T Fenton3, E J Abrams5, H Meyers6, C Rose2, R Yogev1, and the PACTG P1013 Study Team
1Feinberg Sch. of Med., Northwestern Univ., Chicago, IL, USA; 2St. Jude Children's Res. Hosp., Memphis, TN, USA; 3Statistical and Data Analysis Ctr. (SDAC), Harvard Sch. of Publ. Hlth., Boston, MA, USA; 4Univ. of North Carolina at Chapel Hill, Ctr. for AIDS Res., USA; 5Harlem Hosp., New York, NY, USA; and 6Frontier Sci. and Technology Res. Fndn., Amherst, NY, USA
927
Predictive Factors of Virological Success in PI-naive and -experienced HIV-infected Children Treated with a Regimen Including Lopinavir/Ritonavir
C Delaugerre*1, J P Teglas2, J M Treluyer3, V Jullien3, C Rouzioux1, M L Chaix1, and S Blanche4
1Necker Hosp., Paris, France; 2Inserm, Kremlin Bicetre Hosp., Paris, France; 3Saint-Vincent-de-Paul Hosp., Paris, France; and 4Necker Hosp., Paris, France
928
Safety, Tolerability, and Clinical Responses to Tenofovir DF in Combination with other Antiretrovirals in Heavily Treatment-experienced HIV-infected Children: Data through 48 Weeks
R Hazra*1, R Gafni1, F Maldarelli1, A Tullio1, E DeCarlo1, D Bunker1, C Worrell1, J Flaherty2, K Yale2, M Poblenz2, J Zuckerman1, and S Zeichner1
1Bethesda, MD, USA and 2Foster City, CA, USA
929
24-week Safety and Efficacy of Enfuvirtide as Part of an Optimized Antiretroviral Regimen in Adolescents
A Wiznia*1, J Church2, J Stavola3, P Emmanuel4, S Bakshi5, I Febo6, C Cunningham7, R Lawrence8, H Gay9, R Fisher10, P Delora11, L Rowell11, A Bertasso11, and and the T20-310 Study Group
1Jacobi Med. Ctr., Bronx, NY, USA; 2Childrens Hosp. Los Angeles, CA, USA; 3Cornell Univ., New York, NY, USA; 4All Children's Hosp., St. Petersburg, FL, USA; 5Bronx Lebanon Hosp. Ctr., Bronx, NY, USA; 6Univ. of Puerto Rico, San Juan, USA; 7State Univ. of New York Upstate, Med. Univ., Syracuse, USA; 8Univ. of Florida, Hlth. Sci. Ctr., Gainesville, USA; 9Univ. of Mississippi Med. Ctr., Jackson, USA; 10Children's Hosp. of the King's Daughters, Norfolk, VA, USA; and 11Roche, Nutley, NJ, USA
930Efficacy of NNRTI-based HAART among Antiretroviral Naive HIV-infected Children in Thailand: 24-week Result
T Puthanakit*1, N Akarathum2, S Kanjanavanit3, P Wannarit4, J Wongtrakul1, V Sirisanthana1, and T Sirisanthana1
1Chiang Mai Univ., Thailand; 2Sanpathong Hosp., Chiang Mai, Thailand; 3Nakornping Hosp., Chiang Mai, Thailand; and 4Lamphun Hosp., Thailand
931
An Observational Study of the Rate of Opportunistic Infections Events in HIV-infected Children Who Have Demonstrated Immunologic Reconstitution and Who Have Discontinued Prophylaxis
W Dankner*1, S Nachman2, W Hughes3, P Gona4, S Huang4, C Elgie5, R Yogev6, and PACTG Team P1008
1Duke Univ., Durham, NC, USA; 2State Univ. of New York at Stony Brook Hlth. Sci. Ctr., USA; 3St. Jude Children's Res. Hosp., Memphis, TN, USA; 4Harvard Sch. of Publ. Hlth., Boston, MA, USA; 5Frontier Sci. and Technology Res. Fndn., Amherst, NY, USA; and 6Children's Mem. Hosp, Chicago, IL, USA